USA flag logo/image

An Official Website of the United States Government

Flagellar Antigen Rapid Test for Detection of Antibodies to Borrelia

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
22477
Program Year/Program:
1993 / SBIR
Agency Tracking Number:
22477
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ANATRACE, INC.
ANATRACE, INC. 26111 Miles Rd Cleveland, OH 44128 5933
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1993
Title: Flagellar Antigen Rapid Test for Detection of Antibodies to Borrelia
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

PRINCIPAL INVESTIGATOR: Levin, Andrew E. AWARDEE ORGANIZATION: Immunetics 380 Green Street Cambridge, MA 02139 TELEPHONE NUMBER: (617) 492-5416 AWARDEE NUMBER: 200-93-0666 The research program is aimed at providing a simple and reliable serological test which can be used in clinical laboratories, physicians' offices and field stations as an aid in the rapid diagnosis of Lyme Disease. The test is based on the use of microbeads coated with purified Borrelia burgdorferi flagellar antigen for the detection of specific antibodies in patient serum samples. Phase I will concentrate on development of the assay in a rapid test format. The performance of the test will be evaluated against defined serum panels and standard serological assays, including ELISA of whole spirochete sonicates and purified flagella. Performance goals will be high sensitivity and specificity, ease of use, low end-user cost, safe sample handling and storage requirements. In Phase II, the sensitivity and specificity of the test designed in Phase I will be evaluated and subjected to rigorous standardization by screening large numbers of human specimens of various geographical origins and nature (serum, cerebrospinal fluid and dried blood spot eluates). Modifications aimed at increasing specificity through the use of different flagellar antigen preparations, subfragments or synthetic peptides will be investigated. Scaled-up production techniques will be developed and further applicability of the test to species other than man will be explored.

Principal Investigator:

Don N. Gray
4198913037

Business Contact:

Small Business Information at Submission:

Anatrace, Inc.
1280 Dussel Dr. Maumee, OH 43537

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No